A TOXICITY METHOD WITH CALCIUM CYCLAMATE FOR CHRONIC CARCINOGENESIS EXPERIMENTS = METHODE DE DETERMINATION DE LA TOXICITE DU CYCLAMATE DE CALCIUM POUR LES EXPERIMENTATIONS DE CARCINOGENESE CHRONIQUETOTH B.1972; TUMORI; ITAL.; DA. 1972; VOL. 58; NO 3; PP. 137-141; ABS. ITAL.; BIBL. 7REF.Serial Issue

TRAITEMENT ASSOCIE DES CANCERS PAR IRRADIATION ET LA BLEOMYCINE1972; J. JAP. SOC. CANCER THERAPY; JAP.; DA. 1972; VOL. 7; NO 1; PP. 1-15; ABS. ANGL.; BIBL. 8 REF.Serial Issue

OPTIMAL ANTIDOTAL DOSE OF ACTIVATED CHARCOALCHIN L; PICCHIONI AL; BOURN WM et al.1973; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1973; VOL. 26; NO 1; PP. 103-108; BIBL. 1P.Article

LE TRAITEMENT DES MALADES ATTEINTS DE TUBERCULOSE DESTRUCTRICE DES POUMONS PAR DES DOSES INDIVIDUELLES MAXIMALES TOLEREES DE TUBAZIDEBONDAREV IM; TARASOVA EF; NOSKOVA GP et al.1972; PROBL. TUBERK.; S.S.S.R.; DA. 1972; VOL. 58; NO 8; PP. 8-12; ABS. ANGL.; BIBL. 1/2P.Serial Issue

A SUMMARY OF THE DOSIMETRICS FOR EXPOSURES TO ⁶⁰CO OF THE BEAGLES ENTERED INTO THE CRHL LONG-TERM STUDY.ANGLETON GM; LO PRESTI CA.1977; HEALTH PHYS.; G.B.; DA. 1977; VOL. 33; NO 1; PP. 100-103; BIBL. 2 REF.Article

The maximum tolerated dose : the debateMCCONNELL, E. E.Journal of the American College of Toxicology. 1989, Vol 8, Num 6, pp 1115-1120, issn 0730-0913, 6 p.Conference Paper

SUSTAINED BROMOCRIPTINE THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSON'S DISEASELEES AJ; STERN GM.1981; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1981; VOL. 44; NO 11; PP. 1020-1023; BIBL. 9 REF.Article

HERPESVIRUS HOMINIS INFECTION IN NEWBORN MICE: COMPARISON OF THE THERAPEUTIC EFFICACY OF 1-BETA -D-ARABINOFURANOSYLCYTOSINE AND 9-BETA -D-ARABINOFURANOSYLADENINEKERN ER; OVERALL JC JR; GLASGOW LA et al.1975; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1975; VOL. 7; NO 5; PP. 587-595; BIBL. 34REF.Article

LITHIUM CARBONATE AND GRANULOCYTE PRODUCTION: DOSE OPTIMIZATIONSTEIN RS; HOWARD CA; BRENNAN M et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 12; PP. 2696-2701; BIBL. 29 REF.Article

CLINICAL TRIAL OF DROPERIDOL FOR THE DETERMINATION OF THE NEUROLEPTIC THRESHOLD AND THE NEUROLEPTIC-THERAPEUTIC RANGEHAASE HJ; KAUMEIER S; SCHWARZ S et al.1980; INTERNATION. PHARMACOPSYCHIATRY; CHE; DA. 1980; VOL. 15; NO 1; PP. 74-80; BIBL. 7 REF.Article

HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE: RATIONALE AND SPECTRUM OF ANTITUMOR ACTIVITYFREI E III; BLUM RH; PITMAN SW et al.1980; AMER. J. MED.; USA; DA. 1980; VOL. 68; NO 3; PP. 370-376; BIBL. 34 REF.Article

PROBLEMES DE RADIOPROTECTION POSES PAR LES IRRADIATIONS EXTERNES DANS LES UNITES ANIMALESDUTREIX A.1979; SCI. TECH. ANIMAL LAB.; FRA; DA. 1979; VOL. 4; NO 2; PP. 89-93; ABS. ENG; BIBL. 4 REF.Article

STRAIN DIFFERENCES IN MINIMUM ANESTHETIC CONCENTRATIONS IN DROSOPHILA MELANOGASTERGAMO S; OGAKI M; NAKASHIMA TANAKA E et al.1981; ANESTHESIOLOGY; ISSN 0003-3022; USA; DA. 1981; VOL. 54; NO 4; PP. 289-293; BIBL. 22 REF.Article

SAFETY STANDARDS FOR OCCUPATIONAL EXPOSURE OT DICHLOROMETHANESKRABALAK DS; BABISH JG.1983; REGULATORY TOXICOLOGY AND PHARMACOLOGY; ISSN 0273-2300; USA; DA. 1983; VOL. 3; NO 2; PP. 139-143; BIBL. 22 REF.Article

PHASE ISTUDY OF A 5-DAY SCHEDULE OF MITOXANTRONE (DIHYDROXYANTHRACENEDIONE)WYNERT WR; HARVEY HA; LIPTON A et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 6; PP. 1303-1306; BIBL. 6 REF.Article

LES RECOMMANDATIONS DE LA COMMISSION INTERNATIONALE DE PROTECTION RADIOLOGIQUE, 1977STEWART CG.1978; RADIOPROTECTION; FRA; DA. 1978; VOL. 13; NO 4; PP. 237-247; ABS. ENG; BIBL. 16 REF.Article

PHASE I CLINICAL EVALUATION OF 9,10-ANTHRACENEDICARBOXYALDEHYDE (4,5-DIHYDRO-1H-IMIDAZOL-2-YL) HYDRAZONE) DIHYDROCHORIDE (BISANTRENE)BOH SENG YAP; HWEE YONG YAP; BLUMENSCHEIN GR et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 7; PP. 1517-1520; BIBL. 6 REF.Article

NORMALIZATION OF BLOOD GLUCOSE IN PREGNANT DIABETICS WITH THE MAXIMAL TOLERATED DOSE (M.T.D.) OF INSULINROVERSI GD; GARGIULO M; NICOLINI U et al.1980; J. PERINAT. MED.; ISSN 0300-5577; DEU; DA. 1980; VOL. 8; NO 4; PP. 195-202; ABS. GER/ENG; BIBL. 10 REF.Article

TOXIC DOSES OF VITAMIN A FOR PITYRIASIS RUBRA PILARISRANDLE HW; DIAZ PEREZ JL; WINKELMANN RK et al.1980; ARCH. DERMATOL. (CHIC., 1960); ISSN 0003-987X; USA; DA. 1980; VOL. 116; NO 8; PP. 888-892; BIBL. 13 REF.Article

COMPARISON OF THE PLASMA LEVELS OF FENFLURAMINE IN RATS AFTER A TOXIC DOSE AND IN MAN AFTER A MAXIMAL THERAPEUTIC DOSEGARATTINI S; CACCIA S.1979; TOXICOL. LETTERS; NLD; DA. 1979; VOL. 3; NO 5; PP. 285-290; BIBL. 17 REF.Article

CHEMOTHERAPY OF HUMAN HYDATID DISEASE WITH MEBEUDAZOLE: FOLLOW-UP OF 16 CASESBEKHTI A; NIZET M; CAPRON M et al.1980; ACTA GASTRO-ENTEROL. BELG.; BEL; DA. 1980; VOL. 43; NO 1-2; PP. 48-65; ABS. FRE/GER; BIBL. 30 REF.Article

CLINICAL STUDY OF ACLACINOMYCIN AOGAWA M; INAGAKI J; HORIKOSHI N et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 931-934; BIBL. 9 REF.Article

SERIAL HEMODYNAMIC STUDIES DURING THE TREATMENT OF CONGESTIVE HEART FAILURE WITH ISOLATED LOW-DOSE ORAL PRAZOSIN THERAPYREYNS P; ROMNEY D; DESSER KB et al.1979; ANGIOLOGY; USA; DA. 1979; VOL. 30; NO 12; PP. 850-855; BIBL. 14 REF.Article

TENTATIVO DI STIMA DEL RISCHIO GLOBALE DOVUTO ALL' IMPIEGO DIAGNOSTICO DEI RADIONUCLIDI. = TENTATIVE D'ESTIMATION DU RISQUE GLOBAL DU A L'EMPLOI DIAGNOSTIQUE DES RADIONUCLIDESMOMBELLI L; CONTE L.1976; RADIOL. MED.; ITAL.; DA. 1976; VOL. 62; NO 12; PP. 991-1001; ABS. ANGL.; BIBL. 21 REF.Article

Recent progress in the consideration of flavoring ingredients under the food additives amendment. XVI: GRAS substancesSMITH, R. L; FORD, R. A.Food technology (Chicago). 1993, Vol 47, Num 6, pp 104-117, issn 0015-6639, 7 p.Article